ELF3 and hepatocellular carcinoma: ELF3-AS1 might participate in the development of HCC by pathways including GPCR-radioligand binding, M phase, Class A/1 (rhodopsin-like receptors), cell cycle checkpoints, translation, mitotic metaphase and anaphase, signaling by robo receptors, keratinization, and rRNA processing.